# Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

> **NCT07306624** · PHASE2 · RECRUITING · sponsor: **STCube, Inc.** · enrollment: 62 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Nelmastobart and Docetaxel

## Key facts

- **NCT ID:** NCT07306624
- **Lead sponsor:** STCube, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-10
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07306624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07306624, "Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07306624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*